NCT06137105
Thrombopoietin Agonists in Patients With Idiopathic Thrombocytopenic Purpura Not Available Not Available not_yet_recruiting NCT06273956
Explore the Relationship Between Platelet Count and Bleeding Score in ITP No drug interventions Not Available Not Available recruiting NCT06291415
The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP) treatment 1 recruiting NCT06093529
Immune Markers in Pediatric ITP on Second Line Therapy No drug interventions Not Available Not Available not_yet_recruiting NCT06352281
Efficacy and Safety of CAR-T Cells Therapy for Chronic or Refractory Primary Immune Thrombocytopenia (ITP) No drug interventions treatment 1 / 2 recruiting NCT05613296
Real World Evaluation of the Activity and Safety of Fostamatinib in Consecutive Adult Patients With ITP Not Available Not Available not_yet_recruiting NCT05943691
High-dose Dexamethasone Plus Hetrombopag vs High-dose Dexamethasone Alone as Frontline Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Prospective, Multicenter, Randomized Trial No drug interventions treatment 2 recruiting NCT05785819
A Phase 2 Study of VLX-1005 Versus Placebo in Suspected Heparin Induced Thrombocytopenia treatment 2 recruiting NCT02050581
A Chart Review of Rituximab Plus Repeated Cycles of Dexamethasone No drug interventions Not Available Not Available terminated NCT01289509
A Study to Evaluate the Relative Bioavailability and Intra-Subject Variability of Two Lots of E5501 40 mg Tablets Administered Twice as Single Oral Doses to Healthy Subjects treatment 1 completed NCT04070612
National Prospective Cohort for Monitoring Children With Severe Autoimmune Cytopenia. No drug interventions Not Available Not Available completed NCT00157079
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders No drug interventions treatment 3 completed NCT00162006
Efficacy and Safety Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Adult Subjects With Chronic Idiopathic Thrombocytopenic Purpura treatment 2 completed NCT03866577
Safety and Tolerability of M254 in Healthy Volunteers and Immune Thrombocytopenic Purpura (ITP) Patients treatment 1 / 2 terminated NCT02877212
Association of FcγRIIIA Polymorphism and THPO Expression With Response to Eltrombopag in Refractory ITP Patients treatment 3 unknown_status NCT03524612
A Study to Assess the Ability of Eltrombopag to Induce Sustained Response Off Treatment in Subjects With ITP No drug interventions treatment 2 completed NCT01713738
Clinical Trial of Rituximab in Children and Adolescents With Chronic Idiopathic Thrombocytopenic Purpura (ITP) No drug interventions treatment 1 / 2 completed NCT00002250
A Phase I Study of Recombinant Human CD4 Immunoglobulin G (rCD4-lgG) in Patients With HIV-Associated Immune Thrombocytopenic Purpura No drug interventions treatment 1 completed NCT01054443
A Study to Investigate the Efficacy and Safety of Lusutrombopag (S-888711) Tablets Administered to Adults With Immune Thrombocytopenia (ITP) No drug interventions treatment 2 terminated NCT04346654
A Study to Assess Efficacy and Safety of Eltrombopag in Combination With a Short Course of Dexamethasone in Patients With Newly Diagnosed ITP treatment 2 completed NCT04669600
A Phase 2a Study Evaluating BIVV020 in Adults With Persistent/Chronic Immune Thrombocytopenia (ITP) No drug interventions treatment 2 completed NCT04968899
IgIV Plus Prednisone vs High-dose Dexamethasone for ITP treatment 3 recruiting NCT04915482
TPO-RAs Combined With Anti-CD20 Antibody in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies No drug interventions treatment 2 / 3 recruiting NCT02868060
Evaluating the Pharmacokinetics and Pharmacodynamics of Romiplostim in Patients With Immune Thrombocytopenia (ITP) treatment 1 / 2 completed NCT05086744
Basket Study to Assess Efficacy, Safety and PK of Iptacopan (LNP023) in Autoimmune Benign Hematological Disorders treatment 2 terminated NCT03951623
The Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMPL-523 in Immune Thrombocytopenia Patients No drug interventions treatment 1 completed NCT03975361
Autoreactivity Threshold Analysis in Lupus and Immune Thrombocytopenia (Checkpoints ITP and SLE) No drug interventions basic_science Not Available unknown_status NCT00344149
Rituximab as Second Line Treatment for ITP treatment 3 completed NCT06371417
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial) No drug interventions treatment 1 recruiting NCT01666795
Autoantibody Specificity and Response to IVIG in ITP No drug interventions Not Available Not Available completed NCT00515203
Safety and Efficacy Study of Romiplostim (AMG 531) to Treat ITP in Pediatric Subjects No drug interventions treatment 1 / 2 completed NCT00415532
Romiplostim (AMG 531) Versus Medical Standard of Care for Immune (Idiopathic) Thrombocytopenic Purpura treatment 3 completed NCT01444417
Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients treatment 3 completed NCT00454857
Retrospective & Prospective Observational Study of Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) No drug interventions Not Available Not Available completed NCT00305435
Safety Study of AMG 531 in Japanese Subjects With ITP treatment 2 completed NCT04113915
Viral Hepatitis B and C Infection in Patients With Idiopathic Thrombocytopenic Purpura Treated With Triple Therapy Not Available Not Available unknown_status NCT05315778
Anti-BCMA CAR T-Cell Therapy for R/R ITP No drug interventions treatment 2 unknown_status NCT04943042
An Observational, Multicenter Study to Evaluate the Use and Effectiveness of Doptelet® in Patients With ITP Not Available Not Available active_not_recruiting NCT04735588
Investigation on the Incidence and Course of COVID-19 in Patients With Prior, Ongoing or de Novo ITP. Evaluation of the Impact of COVID-19 Pandemic on the Management of ITP No drug interventions Not Available Not Available unknown_status NCT04482777
IL37,Tlymphocytes,NK Cells in Pathogenesis of ITP No drug interventions Not Available Not Available not_yet_recruiting NCT01549054
A Study in Healthy Subjects to Evaluate Bioavailability of 4 Formulations of E5501 treatment 1 completed NCT00909077
The Efficacy of Dexamethasone Versus Dexamethasone Combined With Rituximab in Patients With Newly Diagnosed Idiopathic Thrombocytopenic Purpura (ITP) treatment 3 completed NCT00511147
IGIV Study for Chronic ITP Patients Ages 3-70 treatment 3 completed NCT03123497
Assessment of Quality of Life of Children With Chronic Idiopathic Thrombocytopenic Purpura (Kid's ITP Tools) No drug interventions Not Available Not Available unknown_status NCT00907478
Study on Bone Marrow Morphology in Adults Receiving Romiplostim for Treatment of Thrombocytopenia Associated With Immune Thrombocytopenia Purpura (ITP) treatment 4 completed NCT03412188
The Effect of Eltrombopag on the Expression of Platelet Collagen Receptor GPVI in Pediatric ITP. treatment Not Available completed NCT05492409
Study of the Safety and Immunogenicity of Long-term GNR-069 Therapy in ITP Patients treatment 3 completed NCT01520909
Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body. treatment 3 completed NCT05757570
An Open-label Study of Povetacicept in Subjects With Autoimmune Cytopenias treatment 1 / 2 recruiting NCT01988506
Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases No drug interventions treatment 2 completed NCT00102336
AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Prior to Splenectomy treatment 3 completed NCT04014413
Safety and Efficacy of Fecal Microbiota Transplantation No drug interventions treatment Not Available recruiting NCT00861224
Effects of Long-term Dosing of AMG 531 on Bone Marrow Morphology No drug interventions Not Available Not Available completed NCT01805648
Efficacy and Safety Study of Maintenance Treatment With rhTPO in Thrombocytopenic Subjects With ITP treatment 3 unknown_status NCT01734057
Recombinant Human Thrombopoietin (rhTPO) Combining Rituximab Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP) treatment 3 withdrawn NCT05635266
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives No drug interventions Not Available Not Available recruiting NCT05281068
The Combination of Iguratimod and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia treatment 2 unknown_status NCT05116423
Machine-learning Based Prediction Model in Primary Immune Thrombocytopenia No drug interventions Not Available Not Available unknown_status NCT05118126
Gut Microbiota in ITP No drug interventions Not Available Not Available unknown_status NCT04747080
The Combination of Tacrolimus and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia treatment 2 unknown_status NCT04089267
Evaluating the Efficacy and Safety of Different Human Thrombopoietin (rhTPO) Regimens in the Treatment of Patients With Primary Immune Thrombocytopenia (ITP) No drug interventions treatment 4 completed NCT04703621
The DART Study- Daratumumab Treatment in ITP treatment 2 active_not_recruiting NCT02914054
Therapy of Adults Affected by Idiopathic Thrombocytopenic Purpura With Dexamethasone treatment 2 / 3 completed NCT03465020
Investigation on a Dynamic Cohort of Italian Patients With Active ITP No drug interventions Not Available Not Available unknown_status NCT00508820
An Open Label Study of Romiplostim in Adult Thrombocytopenic Subjects With ITP treatment 3 completed NCT00770562
A Study Evaluating the Addition of MabThera (Rituximab) to Standard Treatment in Patients With Idiopathic Thrombocytopenic Purpura (ITP) treatment 3 completed NCT03421392
Study of Platelets Sialylation by Flow Cytometry for the Differential Diagnosis of ICT No drug interventions Not Available Not Available completed NCT06287567
Lusutrombopag in the Treatment of Immune Thrombocytopenia (ITP) treatment 2 recruiting NCT00749112
Alemtuzumab and Rituximab in the Treatment of Refractory Autoimmune Cytopenias treatment 2 / 3 completed NCT00828750
Clinical Evaluation of Eltrombopag in Chronic Idiopathic Thrombocytopenic Purpura (ITP) treatment 3 completed NCT00475423
A Study of MabThera (Rituximab) in Patients With Idiopathic Thrombocytopenic Purpura. treatment 2 completed NCT00102323
AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to Splenectomy treatment 3 completed NCT01143038
Interventional Study in Adults With Immune Thrombocytopenia Purpura (ITP) Receiving Romiplostim treatment 2 completed NCT00625443
Phase 2, Parallel Group, Rollover Study of AKR-501 in Patients With ChronicITP Who Completed 28 Days of Study Treatment in Protocol 501-CL-003 treatment 2 completed NCT01443351
Long-term Safety Study of Treatment With the Thrombopoietin Agonists Eltrombopag and Romiplostim in Patients With Immune Thrombocytopenia (ITP) No drug interventions Not Available Not Available withdrawn NCT00392951
Sirolimus for Autoimmune Disease of Blood Cells treatment 1 / 2 completed NCT01276561
Single Incision Versus Standard Laparoscopic Splenectomy No drug interventions treatment Not Available withdrawn NCT01433978
A Phase 3, Multicenter, Randomized, Double-blind,Active-controlled, Parallel-group Trial With an Open-labelExtension Phase to Evaluate the Efficacy and Safety of OralE5501 Versus Eltrombopag, in Adults With Chronic ImmuneThrombocytopenia (Idiopathic Thrombocytopenic Purpura) treatment 3 terminated NCT05220878
Comparative Study of Clinical Efficacy and Safety of GNR-069 and Nplate in Patients With ITP treatment 3 completed NCT00116688
Open Label Extension Study of Romiplostim (AMG 531) in Thrombocytopenic Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) treatment 3 completed NCT01609452
MONICA-SC: A Study to Evaluate the Efficacy, Safety and Tolerability of Blisibimod (A-623) Administration in Subjects With ITP treatment 2 / 3 withdrawn NCT00111475
Evaluating the Safety and Efficacy of Romiplostim (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP) treatment 2 completed NCT00603642
P3 Study to Evaluate Efficacy and Safety of AMG 531 in Thrombocytopenic Japanese Subjects With Immune (Idiopathic) Thrombocytopenic Purpura treatment 3 completed NCT01571349
Hemostasis in Patients With Idiopathic Thrombocytopenic Purpura No drug interventions Not Available Not Available completed NCT01525836
rhTPO Combining Rituximab Versus Low-dose Rituximab in Management of ITP treatment 3 completed NCT04904276
Observational Study of Fostamatinib as Second Line Therapy in Adult Patients With Immune Thrombocytopenia (ITP) and Insufficient Response to a Prior Therapy No drug interventions Not Available Not Available terminated NCT05446831
Baricitinib for Steroid-resistant/Relapse Immune Thrombocytopenia No drug interventions treatment 2 unknown_status NCT03864796
Role of CD11a in Pathogenesis of Primary ITP and Effect of Immunosuppressive Therapy on Its Level No drug interventions Not Available Not Available completed NCT04128358
Triple Therapy in Patients With Idiopathic Thrombocytopenic Purpura : What is Behind? No drug interventions health_services_research Not Available unknown_status NCT00244257
Safety Study of GMA161 in Patients With Idiopathic Thrombocytopenic Purpura (ITP) No drug interventions treatment 1 terminated NCT00128882
Treatment of Idiopathic Thrombocytopenic Purpura (ITP) With Subcutaneously Administered Anti-D No drug interventions treatment 2 completed NCT01882127
All-Trans Retinoic Acid (ATRA) Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP) No drug interventions treatment 3 withdrawn NCT00451594
High Dose Dexamethasone Vs. Conventional Dose Prednisolone in Adult ITP No drug interventions treatment 3 completed NCT01734044
rhTPO Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of ITP No drug interventions treatment 3 completed NCT01931644
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions No drug interventions Not Available Not Available completed NCT00888901
Platelet Function in Idiopathic Thrombocytopenic Purpura (ITP) Patients With Eltrombopag No drug interventions diagnostic 4 completed NCT01506414
Recombinant Human Thrombopoietin in Combination With Rituximab in Immune Thrombocytopenia (ITP) No drug interventions treatment 3 completed NCT01713855
Vaccine Response After Rituximab for Chronic, Severe Idiopathic Thrombocytopenic Purpura No drug interventions Not Available Not Available completed NCT04132050
A Clinical Study in Patients With Chronic Idiopathic Thrombocytopenic Purpura in R788 No drug interventions treatment 3 completed NCT03222843
Multicentre, Randomised Phase III Study of the Efficacy and Safety of Hetrombopag Olamine in Idiopathic Thrombocytopenic Purpura (ITP) Patient No drug interventions treatment 3 completed NCT00161564
A Trial to Treat Patients With ITP Who Do Not Achieve a Durable Response to Rituxan Alone No drug interventions treatment 2 withdrawn NCT01437384
Pharmacokinetic and Pharmacodynamic Study in Healthy Subjects Comparing the Interactions Between E5501 and Verapamil and Cyclosporine. No drug interventions treatment 1 completed NCT00860600
Safety and Efficacy Study of PG2 to Treat Idiopathic Thrombocytopenic Purpura (ITP) Patients No drug interventions treatment 2 completed NCT00362349
Ig NextGen 10% in Idiopathic Thrombocytopenic Purpura (ITP) Patients No drug interventions treatment 3 completed NCT00571467
Phase I Safety and Tolerability Study of Staphylococcal Protein A in Adult Patients With Chronic ITP No drug interventions treatment 1 terminated NCT02566603
PRTX-100-203 Open-Label, Dose Escalation Study in Adult Patients With ITP No drug interventions treatment 1 / 2 terminated NCT05995054
A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Immune Thrombocytopenia treatment 2 recruiting NCT02760251
Immunomodulation With Romiplostim in Young Adults With ITP treatment 4 completed NCT04039477
A Phase 2 Study to Evaluate the Safety and Efficacy of KZR-616 in Patients With AIHA and ITP treatment 2 withdrawn NCT06444477
Molecular Analysis of Thrombocytopenia and Cancer (MATAC): Investigating Antigenic Mimicry Between Platelets and Tumor Cells in Patients With Immune Thrombocytopenia (ITP) Associated With Cancer No drug interventions Not Available Not Available not_yet_recruiting NCT05937828
OBS'CEREVANCE: French Cohort of Pediatric Autoimmune Cytopenia No drug interventions Not Available Not Available recruiting NCT02967328
RP% Measurement by FCM as a Diagnostic Test for ITP No drug interventions Not Available Not Available unknown_status NCT06176911
The Combination of Teriflunomide and Danazol for Steroid-resistant/Relapse Immune Thrombocytopenia treatment 2 recruiting NCT04311593
Prognostic Value of CD Markers in Immune Thrombocytopenic Purpura No drug interventions Not Available Not Available unknown_status NCT04518878
Fixed Low-dose Eltrombopag and rhTPO for Immune Thrombocytopenia (FLOWER) treatment 1 unknown_status NCT03304288
The Combination of Low-dose Rituximab and ATRA as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia treatment 2 unknown_status NCT03154385
Efficacy and Safety Assessment of a Treatment Combining Rituximab and Belimumab in Adults With Persistent Immune Thrombocytopenia treatment Not Available completed NCT04993885
Avatrombopag in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies treatment 2 recruiting NCT05023915
A Multicenter Randomized Open-label Study of Diammonium Glycyrrhizinate Enteric-coated Capsule Plus DXM Versus DXM in Treatment of ITP treatment 2 unknown_status NCT03164915
A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj. in Primary Immune Thrombocytopenia (ITP) treatment 3 completed NCT03939637
Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children treatment 3 active_not_recruiting NCT03810352
Association of Platelet Parameters With Bleeding Severity in Children With ITP No drug interventions Not Available Not Available completed NCT03156452
Newly Diagnosed Immune Thrombocytopenia Testing the Standard Steroid Treatment Against Combined Steroid & Mycophenolate treatment 3 completed NCT02298075
Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune Thrombocytopenia Not Available Not Available unknown_status NCT03576742
Severe Immune Cytopenia Registry Www.Sic-reg.Org No drug interventions Not Available Not Available active_not_recruiting NCT05393999
SABRE: A Single-arm Prospective Study Measuring Safety and Tolerability of SARS-CoV-2 Neutralising Antibodies in High-risk Populations No drug interventions prevention 2 withdrawn NCT02868099
Efficacy and Safety of Romiplostim in Adult Subjects With Persistent or Chronic Immune Thrombocytopenia (ITP) treatment 3 completed NCT05459649
Combined Steroid and Cyclosporin as First-line Treatment in Adults With Primary Immune Thrombocytopenia treatment 2 not_yet_recruiting NCT02287649
Polymorphism and Auto-reactive B and T Cells Subsets in Adult's Immune Thrombocytopenia (ITP) No drug interventions diagnostic Not Available completed NCT01869049
The Alteration of Macrophage Function in the Spleen Tissues From Patients With Primary Immune Thrombocytopenia No drug interventions Not Available Not Available withdrawn NCT03520049
Proof-of-Concept: A Pilot, Randomized, Double-Blind Study of Oseltamivir Versus Placebo for Immune Thrombocytopenia treatment 3 unknown_status NCT05931718
Prospective Evaluation of Diagnosis and Treatment of Patients With Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia, Immune Thrombocytopenia, and Chronic Idiopathic/Autoimmune Neutropenia Not Available Not Available recruiting NCT00902018
Eltrombopag and the Bcl-extra-large (xL) Pathway in Idiopathic Thrombocytopenic Purpura (ITP) treatment 2 completed NCT01129024
An Open-label Safety Study of Lusutrombopag (S-888711) in Adults With Chronic Immune Thrombocytopenia (ITP) treatment 2 terminated NCT05932524
Low-dose Baricitinib Plus High-dose Dexamethasone for Patients With Newly Diagnosed Immune Thrombocytopenia treatment 2 recruiting NCT05302024
Efficacy and Safety of Iguratimod in the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia treatment 2 unknown_status NCT02757196
Treatment of ITP With Rituximab and / or Accutane treatment 2 unknown_status NCT05095896
The Serum Lipid Profiles in ITP: a Retrospective Study No drug interventions Not Available Not Available completed NCT01763658
Oxidant Status and Effect of Antioxidant in Immune Thrombocytopenia No drug interventions treatment 2 / 3 unknown_status NCT03377439
The Association Between Platelet Reactivity and Bleeding Risk in Adult ITP No drug interventions Not Available Not Available unknown_status NCT04741139
Post IVIG Medication in Children With Immune Thrombocytopenia treatment 1 active_not_recruiting NCT02203422
A Multicenter Investigation of Recombinant Human Thrombopoietin (rhTPO) Combining Cyclosporin A Versus Cyclosporin A in Management of Steroid-Resistant/Relapsed Immune Thrombocytopenia （ITP） treatment 3 withdrawn NCT05694325
Biologic Characterization of Patients With ITP No drug interventions basic_science Not Available recruiting NCT06073925
Use of Vitamin D as An Adjuvant Treatment in Children With Chronic Idiopathic Thrombocytopenic Purpura No drug interventions supportive_care 0 not_yet_recruiting NCT03201848
The Efficacy and Safety of Huaiqihuang Granule in Children With Chronic Primary Immune Thrombocytopenia No drug interventions treatment 4 active_not_recruiting NCT04217148
The Combination of ATRA and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia treatment 2 completed NCT03258866
The Study of Different Dose Rituximab in the Treatment of ITP treatment 4 completed NCT05522465
Short-course High-dose Prednisone and Dexamethasone in Children With ITP treatment 4 recruiting NCT05685420
Extension Study of Herombopag for Pediatric Patients With Chronic Immune Thrombocytopenia No drug interventions treatment 3 not_yet_recruiting NCT05562882
A Clinical Trial to Assess Safety and Efficacy of Daratumumab in the Treatment of Primary Immune Thrombocytopenia treatment 0 unknown_status NCT04481282
The Combination of Terbutaline and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia treatment 2 unknown_status NCT02279173
Long-term Study of Romiplostim in Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP) treatment 3 completed NCT05046327
Open-Label Study to Evaluate the Safety and Efficacy of Avatrombopag and Remission Rates in Adults With ITP of ≤6 Months treatment 3 withdrawn NCT06281327
Avatrombopag in the Treatment of Pediatric Immune Thrombocytopenia treatment 2 recruiting NCT02153060
An Investigation of Dexamethasone With Different Doses in the Management of Immune Thrombocytopenia (ITP) treatment 2 completed NCT03820960
Risk Factors for Thrombosis in Immune Thrombocytopenia No drug interventions Not Available Not Available completed NCT04588194
Romiplostim, Rituximab and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia treatment 2 unknown_status NCT03177629
H. Pylori Eradication for Moderate ITP No drug interventions treatment 3 unknown_status NCT02063789
An Open Phase 3 Study of IV-Globulin SN Inj.10% to Treat Immune Thrombocytopenia No drug interventions treatment 3 completed NCT05333744
The Combination of Prednisone and Recombinant Human Thrombopoietin for Treatment of Immune Thrombocytopenia in Pregnancy treatment 2 unknown_status NCT01438840
Efficacy and Safety of Oral E5501 Plus Standard of Care for the Treatment of Thrombocytopenia in Adults With Chronic Immune Thrombocytopenia (Amendment 02) treatment 3 completed NCT04516967
Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune Thrombocytopenia for ≥6 Months treatment 3 active_not_recruiting NCT05694767
A Prospective, One-arm and Open Clinical Study of CM313 in the Treatment of Immune Thrombocytopenia No drug interventions treatment 2 recruiting NCT02139501
An Investigation of rhTPO With Different Frequencies in the Management of ITP treatment 3 completed NCT02270801
Recombinant Human Thrombopoietin (rhTPO) in Management of Immune Thrombocytopenia (ITP) in Pregnancy treatment 3 unknown_status NCT02649504
Rituximab and Dexamethasone Followed by Mycophenolate Mofetil or Placebo in Patients With Immune Thrombocytopenia treatment 3 withdrawn NCT05279872
A Study of Zanubrutinib in Patients With ITP treatment 2 completed NCT02834468
DEX Combined With RTX, CSA and IVIG in the Management of Newly Diagnosed ITP Patients treatment 3 unknown_status NCT03229746
Reposition of Second Line Treatment in Chronic Immune Thrombocytopenia treatment 4 completed NCT03395210
A Study of Rilzabrutinib in Adult Patients With Immune Thrombocytopenia (ITP) treatment 2 active_not_recruiting NCT02137681
A Multicentre Investigation of 2 Cycles Rituximab Compared With Standard Regimen in Management of Steroid-Resistant/Relapsed Immune Thrombocytopenia （ITP） treatment 3 withdrawn NCT04056195
Study of Oral SKI-O-703, SYK Inhibitor, in Patients With Persistent and Chronic Immune Thrombocytopenia (ITP) No drug interventions treatment 2 completed NCT03013114
A Single-center Clinical Trial of Bortezomib in Management of Immune Thrombocytopenia (ITP) treatment 2 unknown_status NCT05930314
CNCT19 Cell Injection for Refractory Systemic Lupus Erythematosus treatment 0 enrolling_by_invitation NCT02556814
Caffeic Acid Combining High-dose Dexamethasone in Management of ITP treatment 4 completed NCT04737850
Hetrombopag for Pediatric Patients With Chronic Immune Thrombocytopenia treatment 3 unknown_status NCT01386723
End of EXTEND: Discontinuation of Medication for Patients With Immune Thrombocytopenia Not Available Not Available terminated NCT04005638
Biological Bank for the Patients Followed in a Constitutive Reference Center for Autoimmune Cytopenia No drug interventions Not Available Not Available recruiting NCT05152238
ITP Registry and Accompanying Biospecimen Collection No drug interventions Not Available Not Available recruiting NCT05566990
A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj.10% in Primary Immune Thrombocytopenia (ITP) treatment 3 completed NCT05369364
The Combination of Zanubrutinib and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia treatment 2 not_yet_recruiting NCT03183284
Comparison Between Methyl Prednisolone and Intravenous Dexamethazone in Severe Immune Thrombocytopenic Purpra No drug interventions Not Available Not Available unknown_status NCT01549184
Retrospective Analysis of the Safety and Efficacy of Hydroxychloroquine in Immune Thrombocytopenia No drug interventions Not Available Not Available completed NCT01971684
ICON1: Treatment Decisions and Outcomes in Pediatric Refractory ITP Not Available Not Available completed NCT03324087
Evaluation of HRQoL in Adult With Immune Thrombocytopenia in China No drug interventions Not Available Not Available unknown_status NCT04102033
Eltrombopag in Chronic ITP treatment 4 unknown_status NCT01568333
A Multi-center Study of Low-dose Decitabine for the Treatment of Immune Thrombocytopenia treatment 2 completed NCT03692754
Atorvastatin in Management of Newly Diagnosed ITP treatment 2 / 3 unknown_status NCT06168851
Anti-CD38 Antibody Treating Pediatric Primary Immune Thrombocytopenia (ITP) No drug interventions treatment 2 recruiting NCT05369377
Zanubrutinib and Eltrombopag as Second-line Treatment in Adults With Primary Immune Thrombocytopenia treatment 2 not_yet_recruiting NCT05852847
Low-dose Baricitinib Plus Danazol for Steroid-resistant/Relapse Immune Thrombocytopenia treatment 2 recruiting NCT01880047
Safety and Efficacy of Eltrombopag at Escalated Doses treatment 2 completed NCT06190145
Teriflunomide for Steroid-resistant/Relapse Immune Thrombocytopenia treatment 2 recruiting NCT04368598
The Combination of High-dose Dexamethasone and Acetylcysteine as the Treatment of Newly-diagnosed ITP treatment 2 unknown_status NCT06417398
Preliminary Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases No drug interventions treatment 0 not_yet_recruiting NCT04094805
A Multicenter Randomized Study of Vitamin D Combined With HD-DXM Versus HD-DXM for the Treatment of ITP treatment 4 unknown_status NCT03469661
Differential Diagnostic of Immune ThrombocytoPenia (ITP) and Myelodysplastic Syndrome (MDS) No drug interventions Not Available Not Available completed NCT02401061
PRTX-100-202 Open-Label, Dose Escalation Study in Adult Patients With ITP treatment 1 / 2 terminated NCT05124028
A Study of Orelabrutinib in Patients With ITP treatment 1 / 2 unknown_status NCT04618328
A Study of ATRA in the Treatment of ITP treatment 2 unknown_status NCT02751593
Thrombocytopenia in Gestational Period treatment 2 / 3 unknown_status NCT05020288
A Clinical Trial of the Orelabrutinib in the Management of Refractory ITP treatment 2 unknown_status NCT06556888
Observatory of Immunological Thrombopenic Purpura in the Brest Region No drug interventions Not Available Not Available recruiting NCT05494307
The Combination of Terbutaline and Danazol as the Treatment of Corticosteroid-resistant/Relapse Immune Thrombocytopenia treatment 2 unknown_status NCT04289207
Phase II Trial of Romiplostim With Danazol in Patients With Eltrombopag-resistant Immune Thrombocytopenia treatment 2 unknown_status NCT02859909
This Clinical Study is to Test Efficacy and Safety of BT595 in Chronic Primary Immune Thrombocytopenia (ITP) No drug interventions treatment 3 completed NCT06577909
Prednisone Plus IVIg vs. Prednisone for ITP During Pregnancy treatment 2 recruiting NCT03492515
Recombinant Human Thrombopoietin(rhTPO) in Pregnancy With Immune Thrombocytopenia treatment 3 unknown_status NCT06478537
TPO-RA Treatment on Immune Tolerance Induction of ITP Patients With Sustained Platelet Recovery After Treatment Termination treatment 2 recruiting NCT04516837
Eltrombopag Plus rhTPO Versus Eltrombopag for ITP During the COVID-19 Pandemic (ELABORATE-19) treatment 2 unknown_status NCT03603132
A Study to Evaluate Different Intervals Between Dosing and Feeding on the Pharmacokinetics No drug interventions other 1 completed NCT01974232
A Retrospective Chart Review of Thirty Three Children Who Have Received Clinical Treatment With Either Romiplostim or Eltrombopag From 2009-2013 No drug interventions Not Available Not Available completed NCT03443570
Rituximab Combining Bortezomib Versus Rituximab in Management of ITP treatment 3 unknown_status NCT03033199
Clinical Trial of Gut Microbiota in the Management of Immune Thrombocytopenia treatment 2 unknown_status NCT01727999
Genome-Wide Gene Expression Profiling of Patients With ITP Receiving Thrombopoietin Mimetics No drug interventions Not Available Not Available completed NCT02877706
French Registry of Adult Patients With Immune Thrombocytopenia and Autoimmune Hemolytic Anemia No drug interventions Not Available Not Available recruiting NCT03830749
Safety and Efficacy of Eltrombopag Plus Pulsed Dexamethasone for Subjects With Idiopathic Thrombocytopenic Purpura treatment 2 completed NCT01618734
Eltrombopag and Romiplostim Used Alternatively in Patients With Immune Thrombopenia (ITP): Efficacy and Safety. No drug interventions Not Available Not Available completed NCT05634824
IVIg Plus Low Dose rhTPO for ITP in Pregnancy treatment 2 not_yet_recruiting NCT03965624
Efficacy and Safety of Ixazomib and Dexamethasone Refractory Autoimmune Cytopenia treatment 2 withdrawn NCT04800458
Contribution of Anti-platelet Antibodies Identified With MAIPA Assay in the Demonstration of the Auto-immune Character of a Thrombocytopenia at Diagnosis No drug interventions diagnostic Not Available recruiting NCT01933035
Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias. No drug interventions Not Available Not Available completed NCT06176235
Teriflunomide Plus High-dose Dexamethasone as First-line Treatment in Newly Diagnosed Primary Immune Thrombocytopenia treatment 2 recruiting NCT02834286
Rituximab, Eltrombopag and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia treatment 2 unknown_status NCT02351622
Caffeic Acid Tablets as a Second-line Therapy for ITP No drug interventions treatment 3 completed NCT04320225
Connection Between Vitamin D Level and the Efficacy of Dexamethasone in Immune Thrombocytopenia No drug interventions Not Available Not Available unknown_status NCT02892630
Immune Thrombocytopenia in Pregnancy No drug interventions Not Available Not Available unknown_status NCT03252457
Decitabine Combining Dexamethasone Versus Dexamethasone in Management of ITP No drug interventions treatment 3 unknown_status NCT05468866
The Expression of Immune Checkpoint CD28 rs1980422-related Single-nucleotide Polymorphisms in the Primary Immune Thrombocytopenia No drug interventions diagnostic Not Available unknown_status NCT04562766
Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP) No drug interventions treatment 3 recruiting NCT05654766
Assesment of the Functional Activity of Platelets for the Differential Diagnosis of Thrombocytopathies No drug interventions Not Available Not Available not_yet_recruiting NCT06519565
Safety and Efficacy of PRG-1801 in Recurrent/Refractory Immune Thrombocytopenia (ITP) No drug interventions treatment 0 not_yet_recruiting NCT03998982
Glycyrrhetinic Acid Combined With Dexamethasone in Management of Newly Diagnosed ITP No drug interventions treatment 4 unknown_status NCT05353673
The Combination of Sitagliptin and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia No drug interventions treatment 2 unknown_status NCT03172676
Effects of Helicobacter Pylori Eradication in Children With Chronic Immune Thrombocytopenic Purpura No drug interventions treatment 4 unknown_status NCT05214391
A Prospective, One-arm and Open Clinical Study of Zanubrutinib in the Treatment of Immune Thrombocytopenia No drug interventions treatment 2 unknown_status NCT02642380
Different Cycles of High-dose Dexamethasone for Initial Management of Primary Immune Thrombocytopenia (ITP) No drug interventions treatment 4 withdrawn NCT04638829
Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or Romiplostim No drug interventions treatment 4 completed NCT06199089
A Randomized, Double-blind, Placebo-controlled, and Multi-center Clinical Study of CM313 in the Treatment of Immune Thrombocytopenia No drug interventions treatment 2 recruiting NCT05328804
Herombopag + rhTPO in Severe Immune Thrombocytopenia No drug interventions treatment 3 unknown_status NCT02391272
A Multicenter Study on Recombinant Human Thrombopoietin in Management of ITP in Pregnancy No drug interventions treatment 3 completed NCT02821572
Role of Fcgamma Receptors in Immune Thrombocytopenia (ITP) No drug interventions Not Available Not Available recruiting NCT01864512
Alteration of Different Immune Parameters in Immune Thrombocytopenia （ITP） Patients Receiving Eltrombopag Treatment No drug interventions Not Available Not Available withdrawn NCT06094881
A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Pediatric Primary Immune Thrombocytopenia (ITP) No drug interventions treatment 2 recruiting NCT01976195
High-dose Dexamethasone Combining Thalidomide Versus Dexamethasone Mono-therapy for Management of Newly-diagnosed ITP No drug interventions treatment 2 withdrawn NCT02338414
An Observational Study to Evaluate the Efficacy of Biweekly Romiplostim in Adult Patients With ITP No drug interventions treatment 2 unknown_status NCT05471050
The Combination of Tacrolimus and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia No drug interventions treatment 2 unknown_status NCT05369208
Evaluation of Avatrombopag for the Treatment of Thrombocytopenia in Japanese Adults With Chronic ITP No drug interventions treatment 3 active_not_recruiting NCT03460808
The Combination of Atorvastatin, Acetylcysteine and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia No drug interventions treatment 1 / 2 unknown_status NCT00440037
Open Label Extension Study of AMG 531 in Japanese Subjects With ITP treatment 2 / 3 completed NCT04057703
Balance Benefit / Risk of Immunomodulatory Treatments at the Child and Adolescent for Autoimmune Cytopenia. No drug interventions Not Available Not Available completed NCT01439321
Outcomes Comparison of Chronic Immune Thrombocytopenic Purpura (ITP) Patients Switched to Eltrombopag and Romiplostim No drug interventions Not Available Not Available completed NCT01672151
Efficacy of Rapamycin Therapy With Chronic Immune Thrombocytopenia Not Available Not Available completed NCT01107951
Low-dose Rituximab and High-dose Dexamethasone as First Line Treatment for ITP treatment 2 completed NCT02085993
Study of Patients With ITP Estimating the Proportion Administering Romiplostim Correctly After Receiving Home Administration Training No drug interventions Not Available Not Available completed NCT06523088
A Phase 1a Study of PN20 in Healthy Adult Volunteers treatment 1 completed NCT04056507
Immunological Markers in Adult Patients With Immune Thrombocytopenic Purpura No drug interventions Not Available Not Available completed NCT01668615
Efficacy of Immunomudulatory Therapy With All-trans Retinoid Acid for Adults With Chronic Immune Thrombocytopenia Not Available Not Available completed NCT01255332
Helicobacter Pylori Immune Thrombocytopenic Purpura No drug interventions Not Available Not Available unknown_status NCT01730352
Helicobacter Pylori Treatment in Immune Thrombocytopenic Purpura (ITP) Patients No drug interventions treatment 2 / 3 completed NCT01652599
Eltrombopag and High-dose Dexamethasone as First Line Treatment for IT treatment 2 completed NCT04070599
Initial Hemato-immunological Profile on the Evolution of Immunological Thrombopenic Purpura. No drug interventions basic_science 3 completed NCT04323748
Dose Dense Rituximab for High Risk Newly Diagnosed Acute Immune Thrombocytopenic Purpura treatment 1 recruiting NCT01510873
Health-related Quality of Life and Fatigue in Adult Patients With Primary Immune Thrombocytopenic Purpura (pITP) No drug interventions Not Available Not Available completed NCT01719692
Low-dose Rituximab Regimens in Chinese Adult Patients With Immune Thrombocytopenia treatment Not Available completed NCT00718692
Open Label Trial on the Safety and Efficacy of Sym001 in the Treatment of Immune Thrombocytopenic Purpura (ITP) treatment 2 completed NCT05585944
" Effect of Single-nucleotide Polymorphism of CD40 Gene rs1883832 C/T on the Risk of Immune Thrombocytopenic Purpura " No drug interventions diagnostic Not Available not_yet_recruiting NCT01621204
A Trial of Eltrombopag or Intravenous Immune Globulin Before Surgery for Immune Thrombocytopenia Patients supportive_care 3 completed NCT02076412
A Efficacy and Safety Study of Fostamatinib in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP) treatment 3 completed NCT00774202
Higher Dose of Rituxan Versus Standard Doses of Rituxan With Cyclophosphamide, Vincristine, and Prednisone in Subjects With Chronic ITP treatment 2 / 3 completed NCT00376077
A Randomized Study of IVIG vs. IVIG With High Dose Methylprednisolone in Childhood ITP. treatment 3 completed NCT00426270
Clinical Study to Evaluate the Efficacy and Safety of Octagam 10% in Idiopathic Thrombocytopenic Purpura in Adults treatment 3 completed NCT00005570
An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers No drug interventions Not Available Not Available completed NCT02076399
A Efficacy and Safety Study of R935788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP) treatment 3 completed NCT01390649
A Safety Study of Intravenous Immunoglobulin in Patients With Chronic Immune Thrombocytopenic Purpura (ITP) treatment 4 completed NCT03363334
Expanded Access of Fostamatinib in Patients With Persistent or Chronic Relapsing/Refractory ITP Not Available Not Available no_longer_available NCT00991939
Initial Treatment of Patients With Immune Thrombocytopenic Purpura treatment 3 terminated NCT05093257
Study of T Cells and Natural Killer Cells Expression in Patients With Immune Thrombocytopenic Purpura No drug interventions Not Available Not Available unknown_status NCT02273960
Study to Evaluate Safety and Efficacy in Adult Subjects With ITP No drug interventions treatment 1 / 2 completed NCT00621894
Oral LGD-4665 Versus Placebo in Adults With Immune Thrombocytopenic Purpura (ITP) for 6 Weeks Plus Open Treatment Continuation No drug interventions treatment 2 completed NCT02077192
Open Label Study of R788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP) No drug interventions treatment 3 completed NCT05835050
Assessment of Serum interleukin10 Level in Patients With Immune Thrombocytopenic Purpura at Sohag University Hospital No drug interventions diagnostic Not Available not_yet_recruiting NCT00168038
Treatment of Chronic Immune Thrombocytopenic Purpura (ITP) With Intravenous Immunoglobulin IgPro10 No drug interventions treatment 3 completed NCT00441090
Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP) No drug interventions treatment 2 completed NCT03010202
The PROLONG Trial - Rituximab Maintenance Therapy in ITP No drug interventions treatment 3 active_not_recruiting NCT05506033
Optimization of Glucocorticoid Taper Strategies for SLE-ITP No drug interventions treatment Not Available enrolling_by_invitation NCT03275454
A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple- Dose BIVV009 in Participants With Chronic Immune Thrombocytopenia (ITP) treatment 1 completed NCT01356511
High-dose Dexamethasone Versus Conventional Dose Prednisone for Initial Treatment of Primary Immune Thrombocytopenia (ITP) treatment 4 completed NCT05438875
The Combination of ATRA and Eltrombopag as the Treatment of Steroid-resistant/Relapse ITP Based on MSC-C5b-9 treatment 3 recruiting NCT02281370
Drug-drug Interaction Study of Eltrombopag and Cyclosporine in Healthy Subjects other 1 completed NCT00706342
Pilot Study of Fostamatinib Disodium/R935788 for the Treatment of Adult Refractory Immune Thrombocytopenic Purpura (ITP) treatment 2 completed NCT02334813
Daily Prednisone Versus Pulsed Dexamethasone in Treatment-naïve Adult Patients With Immune Thrombocytopenia treatment 3 completed NCT00220727
Rapid Infusion Of Immune Globulin Intravenous (IGIV) In Patients With ITP treatment 2 completed NCT02403440
A Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients No drug interventions treatment 1 unknown_status NCT01327872
Subject Variability in Two Lots of E5501 Administered to Fed and Fasted Healthy Subjects treatment 1 completed NCT00487968
Eltrombopag Taste Testing in Healthy Adult Volunteers treatment 1 completed NCT00540423
Clinical Evaluation of SB-497115-GR in Chronic Idiopathic Thrombocytopenic Purpura (ITP) treatment 3 completed NCT02201290
A Long-term Safety Study of Eltrombopag in Pediatric Patients With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) treatment 3 completed NCT02009761
Multiple Rising Does Study (Subcutaneous Doses) of BI 655064 in Male and Female Patients With Chronic Primary Immune Thrombocytopenic Purpura (ITP). No drug interventions treatment 1 terminated NCT02891109
Regulatory B Cells and Chronic Immune Thrombocytopenia No drug interventions Not Available Not Available completed NCT00005652
Phase II Study of Rituximab in Patients With Immune Thrombocytopenic Purpura treatment 2 completed NCT00547066
Study of Veltuzumab (hA20) at Different Doses in Patients With ITP No drug interventions treatment 1 / 2 terminated NCT01317966
Recombinant Human Interleukin-11 Combination Low-dose Rituximab in Immune Thrombocytopenia No drug interventions Not Available Not Available withdrawn NCT01610180
Eltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs) No drug interventions treatment 2 completed NCT00372892
Pilot Study of Rituximab for the Treatment of Acute Immune Thrombocytopenic Purpura (ITP) No drug interventions prevention 2 completed NCT00151840
Efficacy and Safety of IVIG-L in ITP Patients No drug interventions treatment 3 completed NCT01101295
The ITP-RITUX Cohort: Rituximab in Immune ThrombocytoPenia. No drug interventions Not Available Not Available unknown_status NCT00699140
Clinical Trial in Patients Diagnosed With Immune Thrombocytopenic Purpura No drug interventions treatment 3 completed